Picture of Hammerson logo

HMSO Hammerson News Story

0.000.00%
gb flag iconLast trade - 00:00
FinancialsAdventurousMid CapNeutral

REG - Hammerson PLC - Publication of Final Terms

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251016:nRSP7020Da&default-theme=true

RNS Number : 7020D  Hammerson PLC  16 October 2025

HAMMERSON PLC

16 October 2025

Hammerson plc

PUBLICATION OF FINAL TERMS

The Final Terms dated 13 October 2025 relating to the issuance by Hammerson
plc (the "Issuer") of EUR 350 million 3.500 per. cent notes due 2032 (the
"Notes") are available for viewing.

The Final Terms will shortly be made available on the Issuer's website. Please
paste the following URLs into the address bar of the browser:

https://www.hammerson.com/investors/debt-investors
(https://www.hammerson.com/investors/debt-investors)

A copy of the Final Terms has been submitted to the National Storage Mechanism
and is available for inspection at:

https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

The Notes have been issued under the £5,000,000,000 Euro Medium Term Note
Programme of the Issuer (the "Programme").

The Final Terms should be read and construed in conjunction with the
prospectus dated 15 April 2025, as supplemented by the prospectus supplement
dated 4 September 2025 (the "Prospectus").

Enquiries

Richard Sharp, Director of Treasury and Insurance
Tel: + 44 (0) 207 887 1119 E:richard.sharp@hammerson.com

Hammerson Investor Contacts

Josh Warren, Director of Group Performance and Investor Relations
T: +44 (0) 20 7887 1053 E: josh.warren@hammerson.com

MHP for Hammerson Media
Ollie Hoare and Charles Hirst

T: +44 (0)20 3128 8100 E: Hammerson@mhpgroup.com

DISCLAIMER - INTENDED ADDRESSEES

EU MiFID II professionals/ECPs only/No EEA PRIIPs KID

UK MiFIR professionals/ECPs only/No UK PRIIPs KID

Please note that the information contained in the Prospectus may be addressed
to and/or targeted at persons who are residents of particular countries (as
specified in the Prospectus) only and is not intended for use and should not
be relied upon by any person outside these countries and/or to whom the offer
contained in the Prospectus is not addressed. Prior to relying on the
information contained in the Prospectus, you must ascertain from the
Prospectus whether or not you are part of the intended addressees of the
information contained therein.

In particular, neither this announcement nor the Prospectus shall constitute
an offer to sell or the solicitation of an offer to buy securities in the
United States or in any other jurisdiction in which such offer, solicitation
or sale would be unlawful prior to registration, exemption from registration
or qualification under the securities law of any such jurisdiction.

The Notes have not been and will not be registered under the United States
Securities Act of 1933, as amended (the "Securities Act"), or any United
States ("U.S.") state securities laws and, unless so registered, may not be
offered or sold or (in the case of Notes in bearer form) delivered within the
United States or to, or for the account or benefit of, U.S. persons as defined
in Regulation S under the Securities Act ("Regulation S") except pursuant to
an exemption from or in a transaction not subject to the registration
requirements of the Securities Act and applicable U.S. state securities laws.

Your right to access this service is conditional upon complying with the above
requirements.

 

The announcement above has also been released on the SENS system of the
Johannesburg Stock Exchange and on Euronext Dublin.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  PFTEAFEKFAASFFA



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Hammerson

See all news